Konrad P. Wirz
Direttore Finanziario/CFO presso Speedel Pharma AG
Profilo
Konrad P.
Wirz is Chief Financial Officer of Speedel Pharma AG.
Previously, he was Chief Financial Officer of Sandoz Agro, Inc., Northrup King (US), Schweizerhall, and Actelion Ltd.
He has experience in the corporate valuations, controlling, and strategic financial planning.
Mr. Wirz holds a degree in Business Administration.
Posizioni attive di Konrad P. Wirz
| Società | Posizione | Inizio |
|---|---|---|
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Konrad P. Wirz
| Società | Posizione | Fine |
|---|---|---|
| ACINO HOLDING AG | Direttore Finanziario/CFO | - |
| ACTELION | Direttore Finanziario/CFO | - |
Sandoz Agro, Inc.
 Sandoz Agro, Inc. Chemicals: AgriculturalProcess Industries Sandoz Agro, Inc. provides animal health support services and manufactures pesticides. The company was headquartered in Des Plaines, IL. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Sandoz Agro, Inc.
Sandoz Agro, Inc. Chemicals: AgriculturalProcess Industries Sandoz Agro, Inc. provides animal health support services and manufactures pesticides. The company was headquartered in Des Plaines, IL. | Process Industries |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Health Technology |
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Konrad P. Wirz
